Risk factors for relapse and surgery rate in children with Crohn’s disease

被引:0
作者
Iva Hojsak
Ana Močić Pavić
Zrinjka Mišak
Sanja Kolaček
机构
[1] University of Zagreb,Referral Center for Pediatric Gastroenterology and Nutrition, Children’s Hospital Zagreb, School of Medicine
来源
European Journal of Pediatrics | 2014年 / 173卷
关键词
Crohn’s disease; Corticosteroids; Early treatment; Enteral nutrition; Surgery;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to evaluate risk factors associated with the relapse rate in the first year and the need for surgery in children with Crohn’s disease (CD). Data of all children (n = 74) diagnosed with CD from January 2004 to June 2011 were retrospectively analyzed. Multivariate Cox proportional hazards regression model was used to assess whether important clinical variables at diagnosis (age, presence of perianal disease, first induction therapy, first maintenance therapy, levels of Pediatric CD Activity Index (PCDAI), C-reactive protein (CRP), and standard deviation score (SDS) for height for weight) were associated with the risk of clinical recurrence in the first year and need for surgery during follow-up. Relapse occurred in 36 (48.6 %) patients in the first year from diagnosis. The only significant parameter associated with negative risk of relapse in the first year was exclusive enteral nutrition (EEN) used as induction therapy (hazard ratio (HR) 0.469, 95 % confidence interval (CI) 0.232–0.948). EEN induced remission in 84.2 % of patients. The only risk associated with EEN treatment failure was the involvement of the upper gastrointestinal tract. During the follow-up, 25 (33.7 %) patients underwent surgery. The multivariate Cox regression model failed to recognize significant risk factor for surgery. Conclusion: This study underlines the importance of early EEN in the treatment of CD; it is not only efficacious in the remission induction but could also prevent relapse in the first year.
引用
收藏
页码:617 / 621
页数:4
相关论文
共 232 条
[1]  
Afzal NA(2005)Colonic Crohn’s disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved Dig Dis Sci 50 1471-1475
[2]  
Davies S(2012)An update of the role of nutritional therapy in the management of Crohn’s disease J Gastroenterol 47 872-882
[3]  
Paintin M(1994)Polymeric nutrition as the primary therapy in children with small bowel Crohn’s disease Aliment Pharmacol Ther 8 609-615
[4]  
Arnaud-Battandier F(2006)Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn’s disease Dig Liver Dis 38 381-387
[5]  
Walker-Smith JA(2006)Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: a randomized controlled open-label trial Clin Gastroenterol Hepatol 4 744-753
[6]  
Murch S(1995)The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn’s disease Aliment Pharmacol Ther 9 547-552
[7]  
Heuschkel R(2009)The use of exclusive enteral nutrition for induction of remission in children with Crohn’s disease demonstrates that disease phenotype does not influence clinical remission Aliment Pharmacol Ther 30 501-507
[8]  
Fell J(2006)Exclusive enteral feeding as primary therapy for Crohn’s disease in Australian children and adolescents: a feasible and effective approach J Gastroenterol Hepatol 21 1609-1614
[9]  
Alhagamhmad MH(2013)Use of exclusive enteral nutrition in paediatric Crohn’s disease in the Netherlands J Crohn’s Colitis 7 263-270
[10]  
Day AS(2013)Disease phenotype at diagnosis in pediatric Crohn’s disease: 5-year analyses of the EUROKIDS registry Inflamm Bowel Dis 19 378-385